Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Antipsychotic drug users may twice as likely to experience heart attack than non-users

Antipsychotic drug users may twice as likely to experience heart attack than non-users

Drug-repositioning strategy could help combat Chikungunya virus

Drug-repositioning strategy could help combat Chikungunya virus

Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

Certain genetic markers linked with depression can also predict who may benefit from exercise

Certain genetic markers linked with depression can also predict who may benefit from exercise

Existing non-antibiotic therapeutic drugs could help combat antibiotic-resistant pathogens

Existing non-antibiotic therapeutic drugs could help combat antibiotic-resistant pathogens

Researchers examine effectiveness of antipsychotic drugs to prevent or treat delirium

Researchers examine effectiveness of antipsychotic drugs to prevent or treat delirium

Physical, mental training may improve health of young schizophrenia patients

Physical, mental training may improve health of young schizophrenia patients

Clinical pharmacists in health care teams may improve quality, safety of patient care

Clinical pharmacists in health care teams may improve quality, safety of patient care

Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Janssen announces CHMP positive opinion for use of paliperidone palmitate 3-monthly injection for schizophrenia treatment

Lack of ARHGAP33 molecule causes neuropsychiatric disorders-related abnormal higher brain functions

Lack of ARHGAP33 molecule causes neuropsychiatric disorders-related abnormal higher brain functions

Genetic syndrome may underlie some Parkinson's cases

Genetic syndrome may underlie some Parkinson's cases

Unnecessary transitions can lead to increased health problems in older adults with dementia

Unnecessary transitions can lead to increased health problems in older adults with dementia

Antipsychotic medications may not be effective in preventing delirium in hospitalized patients

Antipsychotic medications may not be effective in preventing delirium in hospitalized patients

Warning of increased mortality risk for PD patients taking antipsychotics

Warning of increased mortality risk for PD patients taking antipsychotics

Antipsychotic drugs may do significantly more harm to Parkinson's disease patients

Antipsychotic drugs may do significantly more harm to Parkinson's disease patients

Could prebiotics benefit early life brain development? An interview with Dr Phil Burnet

Could prebiotics benefit early life brain development? An interview with Dr Phil Burnet

Immune-suppressing drug can improve cognitive ability of patients with schizophrenia

Immune-suppressing drug can improve cognitive ability of patients with schizophrenia

Understanding the pathophysiology of bipolar disorder

Understanding the pathophysiology of bipolar disorder

Coordinated specialty care more cost-effective for young people with first episode psychosis

Coordinated specialty care more cost-effective for young people with first episode psychosis

Add-on lamotrigine enhances bipolar depression treatment

Add-on lamotrigine enhances bipolar depression treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.